Related Experiment Videos

Treatment of pain in sickle-cell crisis

B E Rosenbloom, K R Tanaka

The New England Journal of Medicine

|August 4, 1994

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48-month longitudinal cohort study.

Clinical genetics·2008

Primary hepatic carcinoid tumor presenting as Cushing's syndrome.

Journal of endocrinological investigation·2007

Desferrioxamine (DFO) conjugated with starch decreases NAD redox potential of intact red blood cells (RBC): evidence for DFO as an extracellular inducer of oxidant stress in RBC.

American journal of hematology·2000

The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease.

Archives of internal medicine·2000

Oral L-glutamine therapy for sickle cell anemia: I. Subjective clinical improvement and favorable change in red cell NAD redox potential.

American journal of hematology·1998

Increased red cell glutamine availability in sickle cell anemia: demonstration of increased active transport, affinity, and increased glutamate level in intact red cells.

The Journal of laboratory and clinical medicine·1997

See all related articles